Single-Cell Dissection of Sarcomas Reveals Therapeutic Vulnerabilities in Cancer Cells and Their Microenvironment

Thursday, January 28, 2027 at 2:10 PM to 2:40 PM · 30 min. (Europe/London)
Single-Cell Stage
Day 2 - Thursday 28th January
CancerSingle-Cell

Information

  • Liposarcomas (LPS) are rare, heterogenous and malignant tumours. LPS progression mechanisms are poorly understood, and current understanding of the immune, fibroblast and endothelial populations in the tumour microenvironment remains limited. 
  • We conducted a comprehensive assessment of single-cell RNAseq of Liposarcoma samples which highlighted transcriptionally distinct cell clusters, and varying functional roles that reflect on differences in tumour aggressiveness, invasion and plasticity. 
  • Analysis of cell-cell communication and copy number status also identified unique signaling patterns for tumour cells and non-tumour cell populations that present routes for targeted therapy. 
  • Overall, our analysis identified multiple avenues that can be used for profiling Liposarcoma towards stratified treatment.